1. Panels
  2. Membranoproliferative glomerulonephritis including C3 glomerulopathy
The latest signed off version for the GMS is v3.6. The current version, shown here, may differ from the signed-off version.

Membranoproliferative glomerulonephritis including C3 glomerulopathy (Version 3.8)

Level 2: Renal

Relevant disorders: PMG, MPGN, Primary Membranoproliferative Glomerulonephritis, Primary membranoproliferative glomerulonephritis, Membranoproliferative glomerulonephritis, R197
Panel types: Rare Disease 100K, GMS Rare Disease Virtual, GMS Rare Disease, Component Of Super Panel, GMS signed-off
Latest signed off version: v3.6 (30 Apr 2025)
Previously signed off versions: v3.4, v3.0, v2.13
Previous code: 58c805938f6203413360f1cb
Description
This panel is used for clinical indication 'R197 Membranoproliferative glomerulonephritis including C3 glomerulopathy' in the NHS Genomic Medicine Service.

Further information on the testing criteria and any overlapping clinical indications can be found within (https://www.england.nhs.uk/publication/national-genomic-test-directories/) under 'R197 Membranoproliferative glomerulonephritis including C3 glomerulopathy'.

A version of this panel has been signed off under NHS Genomic Medicine Service governance (see 'Latest signed off version' in the panel header information).

This panel will continue to be curated based on external reviews and Genomics England curation. New changes will be reflected in an increase to the minor version of the panel and details of these can be viewed in the 'Panel Activity' page. Periodically, these changes will be reviewed by a NHS Genomic Medicine Service evaluation process. The content that is agreed for the GMS panels will be reflected in an updated signed off version number.

CNVs, STRs and genes encoded by the mitochondrial genome may not be routinely included in the analysis where the panel is NOT delivered by WGS. Please contact your Genomic Laboratory Hub for information regarding specific queries.

This panel was originally developed for the 100,000 Genomes Project and is still being used for participants in the project.  For the rare disease eligibility criteria refer to: https://www.genomicsengland.co.uk/rarediseasecriteria100K

This panel includes BRIDGE consortium Tier 1 genes from NIHR BioResource – Rare Diseases Study (NIHRBR-RD) sent by Dr Karyn Megy, WGS Clinical Feedback Lead and incorporates pertinent genes associated to PMG. The following experts from the BRIDGE consortium NIHRBR-RD contributed to this panel :  Dr Daniel Gale, University College London.
Panel Activity

11 reviewers

  • Daniel Gale (UCL)

    Group: GeCIP domain
    Workplace: Research lab

  • Sarah Leigh (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Louise Daugherty (Genomics England Curator)

    Group: Other
    Workplace: Other

  • BRIDGE consortium (NIHRBR-RD)

    Group: Other
    Workplace: Other

  • Arianna Tucci (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Eleanor Williams (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Anna de Burca (Oxford University Hospitals NHS Foundation Trust)

    Group: NHS Genomic Medicine Centre
    Workplace: NHS clinical service

  • Ivone Leong (Genomics England Curator)

    Group: Other
    Workplace: Other

  • Catherine Snow (Genomics England)

    Group: Other
    Workplace: Other

  • David Kavanagh (Newcastle upon Tyne NHS hospitals trust)

    Group: NHS Genomic Medicine Centre
    Workplace: NHS clinical service

  • Achchuthan Shanmugasundram (Genomics England Curator)

    Group: Other
    Workplace: Other

9 Entities

9 reviewed, 8 green

List Entity Reviews Mode of inheritance Details
9 Entitiess
Green List (high evidence)
C3
6 reviews
2 green 1 red
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • Hemolytic uremic syndrome, atypical, susceptibility to, 5, OMIM:612925
  • C3 glomerulopathy
  • C3G
Tags
Green List (high evidence)
CFB
7 reviews
1 green 2 red
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • Haemolytic uraemic syndrome
  • aHUS
  • Hemolytic uremic syndrome, atypical, susceptibility to, 4, 612924
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • MPGN
  • Membranoproliferative glomerulonephritis
Tags
Green List (high evidence)
CFH
5 reviews
3 green
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • Hemolytic uremic syndrome, atypical, susceptibility to, 1, 235400
  • Dense Deposit Disease
  • Membranoproliferative Glomerulonephritis Type II
  • Immune-complex-mediated MPGN
Tags
Green List (high evidence)
CFHR1
4 reviews
3 green
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
Phenotypes
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • Hemolytic uremic syndrome, atypical, susceptibility to, 235400
  • Immune-complex-mediated MPGN
Tags
  • currently-ngs-unreportable
Green List (high evidence)
CFHR2
4 reviews
3 green
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
Phenotypes
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • Immune-complex-mediated MPGN
Tags
  • currently-ngs-unreportable
  • gene-checked
Green List (high evidence)
CFHR5
7 reviews
2 green
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • Nephropathy due to CFHR5 deficiency, OMIM:614809
  • Immune-complex-mediated MPGN
  • CFHR5 nephropathy
  • Haematuria
  • Chronic Kidney Disease
  • Proteinuria
  • End stage renal disease
Tags
  • currently-ngs-unreportable
Green List (high evidence)
CFI
7 reviews
2 green 2 red
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
  • Immune-complex-mediated MPGN
  • Hemolytic uremic syndrome, atypical, susceptibility to, 3,612923
Tags
Green List (high evidence)
DGKE
4 reviews
1 green 1 red
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Green
  • NHS GMS
Phenotypes
  • Haemolytic uraemic syndrome
  • aHUS
  • Hemolytic uremic syndrome, atypical, susceptibility to, 7, 615008
  • Nephrotic syndrome, type 7, 615008
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
Tags
Red List (low evidence)
CD46
2 reviews
1 red
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Sources
  • Expert list
  • Expert Review Red
Phenotypes
  • Haemolytic uraemic syndrome
  • aHUS
  • Hemolytic uremic syndrome, atypical, susceptibility to, 2, 612922
  • C3 glomerulopathy
  • C3G
  • Immune complex MPGN
  • IC-MPGN
Tags

Major version comments

  • 2023-03-22 16:05 Catherine Snow (Genomics England) promoted panel to 3.0
    The content of this panel has been updated in accordance with changes agreed with the NHS Genomic Medicine Service. The panel was promoted to the next major version (3.0) following this.

    2019-08-19 11:53 Ellen McDonagh (Genomics England Curator) promoted panel to 2.0
    The content of this panel (version 1.16) was signed off under NHS Genomic Medicine Service governance on (19/August/2019). The panel was promoted to the next major version (version 2.0) as a result of this.

    2017-12-15 16:48 Louise Daugherty (Genomics England) promoted panel to 1.0
    15th December 2017. Panel reviews were assessed, and panel was revised according to reviews and further curation by Arianna Tucci and Louise Daugherty

Downloads

Download lists

  • Whole panel
  • Green list (high evidence)
  • Green and Amber Genes
  • Amber Genes
  • Red list (low evidence)

Download Version